CEUS or Contrast enhanced Ultrasound

DRUG4 trials

Sponsors

Mayo Clinic, Turku University Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, The First Affiliated Hospital of Xiamen University

Conditions

Focal Liver LesionHematomaHepatic LesionsObesity and Overweight

Phase 4

Total-body Glucose Utilization in Obesity

RecruitingNCT06739473

Turku University HospitalObesity and Overweight

Start: 2023-01-25End: 2024-12-31Target: 60Updated: 2024-12-18

Unknown Phase

Utility of Real-Time Contrast Enhanced Ultrasound (CEUS) in the Evaluation of Soft Tissue Hematomas

CompletedNCT03357081

Mayo ClinicHematoma

Start: 2018-02-27End: 2019-09-22Updated: 2022-02-01

The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods

RecruitingNCT06876805

IRCCS Azienda Ospedaliero-Universitaria di BolognaFocal Liver Lesion

Start: 2024-08-01End: 2027-04-01Target: 100Updated: 2025-03-14

Comparative Diagnostic Yield of Contrast-Enhanced Versus Conventional Ultrasound Guidance for Coaxial Biopsy of Hepatic Lesions

CompletedNCT07249268

The First Affiliated Hospital of Xiamen UniversityHepatic Lesions

Start: 2022-01-01End: 2025-05-31Updated: 2025-12-09